https://seekingalpha.com/article/43...vidminus-19-fda-fast-tracked-therapy-for-ards
A very biased article with MESO never being mentioned in regard to patents, history or coming investigations (the author Wall Street Titan discloses a long interest in ATHX), nevertheless a comprehensive look at where Athersys stands in its endeavours to get its Multistem MSC treatment commercialised for ARDS. Will both MSB and Athersys both share the spoils when/if the FDA approves MSCs for ARDS? Is it advantage ATHX at the present time with BARDA and fast tracking behind it? Get in there MSB.
Mesoblast owns the patents . The science is now proven ., page-17
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.055(5.24%) |
Mkt cap ! $1.261B | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.13 | $1.04 | $6.781M | 6.207M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 43856 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 66000 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |